Stock listing
NASDAQ:SABS SAB Biotherapeutics, Inc. Stock
Home listing (NASDAQ) of SAB Biotherapeutics, Inc.
Follow SAB Biotherapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SABS
$3.35 USD +0.12 (+3.7%)
Close on Oct 30, 2026
- Day range
- $3.11 – $3.37 USDOct 30, 2026
- Volume
- 741,050 sharesOct 30, 2026
- Market cap
- $304.8M USDAt the close on Oct 30, 2026 · price × 90.99M shares outstanding
- 52-week range
- $2.44 – $5.15 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.75M USDMedian day 396,900 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SABS · Home | $3.35 USD | +0.12 (+3.7%) | 741,050 | $3.20 | $3.365 | $3.112 | $3.23 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SABS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.35 | +0.12 | +3.7% | $3.20 | $3.365 | $3.112 | 741,050 | |
| $3.23 | +0.03 | +0.9% | $3.16 | $3.36 | $3.16 | 458,274 | |
| $3.20 | +0.13 | +4.2% | $3.04 | $3.22 | $3.01 | 347,699 | |
| $3.07 | +0.28 | +10.0% | $2.80 | $3.085 | $2.80 | 646,572 | |
| $2.79 | -0.05 | -1.8% | $2.91 | $2.94 | $2.765 | 324,347 | |
| $2.84 | -0.20 | -6.6% | $2.98 | $3.04 | $2.82 | 1,015,800 | |
| $3.04 | +0.22 | +7.8% | $2.83 | $3.08 | $2.83 | 710,200 | |
| $2.82 | -0.06 | -2.1% | $2.88 | $2.99 | $2.795 | 388,800 | |
| $2.88 | +0.28 | +10.8% | $2.59 | $2.93 | $2.554 | 814,500 | |
| $2.60 | +0.07 | +2.8% | $2.53 | $2.645 | $2.44 | 602,300 | |
| $2.53 | -0.06 | -2.3% | $2.59 | $2.63 | $2.47 | 756,900 | |
| $2.59 | +0.10 | +4.0% | $2.51 | $2.62 | $2.48 | 787,900 | |
| $2.49 | -0.19 | -7.1% | $2.64 | $2.72 | $2.45 | 853,100 | |
| $2.68 | -0.15 | -5.3% | $2.84 | $2.875 | $2.615 | 893,000 | |
| $2.83 | -0.15 | -5.0% | $2.99 | $3.00 | $2.80 | 359,000 | |
| $2.98 | +0.09 | +3.1% | $2.905 | $3.02 | $2.81 | 659,600 | |
| $2.89 | +0.01 | +0.3% | $2.85 | $2.93 | $2.76 | 1,135,400 | |
| $2.88 | -0.05 | -1.7% | $2.90 | $2.965 | $2.81 | 679,300 | |
| $2.93 | -0.17 | -5.5% | $3.12 | $3.16 | $2.915 | 663,600 | |
| $3.10 | +0.12 | +4.0% | $3.00 | $3.25 | $2.855 | 866,200 | |
| $2.98 | -0.08 | -2.6% | $3.10 | $3.12 | $2.96 | 415,800 | |
| $3.06 | -0.11 | -3.5% | $3.15 | $3.225 | $3.04 | 425,500 | |
| $3.17 | -0.05 | -1.6% | $3.23 | $3.40 | $3.16 | 487,800 | |
| $3.22 | +0.005 | +0.2% | $3.24 | $3.31 | $3.19 | 1,061,500 | |
| $3.215 | -0.075 | -2.3% | $3.335 | $3.335 | $3.14 | 697,900 | |
| $3.29 | -0.06 | -1.8% | $3.36 | $3.49 | $3.27 | 2,445,800 | |
| $3.35 | -0.04 | -1.2% | $3.38 | $3.44 | $3.25 | 544,200 | |
| $3.39 | -0.11 | -3.1% | $3.49 | $3.55 | $3.31 | 406,700 | |
| $3.50 | +0.11 | +3.2% | $3.42 | $3.56 | $3.42 | 739,000 | |
| $3.39 | -0.12 | -3.4% | $3.51 | $3.55 | $3.39 | 379,100 | |
| $3.51 | +0.01 | +0.3% | $3.49 | $3.565 | $3.49 | 1,973,500 | |
| $3.50 | +0.11 | +3.2% | $3.43 | $3.52 | $3.42 | 374,500 | |
| $3.39 | -0.02 | -0.6% | $3.45 | $3.49 | $3.35 | 452,400 | |
| $3.41 | -0.05 | -1.4% | $3.45 | $3.508 | $3.32 | 284,300 | |
| $3.46 | +0.05 | +1.5% | $3.42 | $3.51 | $3.395 | 237,500 | |
| $3.41 | -0.01 | -0.3% | $3.45 | $3.54 | $3.38 | 712,000 | |
| $3.42 | -0.06 | -1.7% | $3.48 | $3.53 | $3.395 | 328,600 | |
| $3.48 | -0.15 | -4.1% | $3.61 | $3.65 | $3.47 | 201,000 | |
| $3.63 | -0.09 | -2.4% | $3.70 | $3.75 | $3.62 | 171,300 | |
| $3.72 | 0.00 | 0.0% | $3.72 | $3.75 | $3.695 | 110,600 | |
| $3.72 | -0.03 | -0.8% | $3.76 | $3.79 | $3.71 | 161,600 | |
| $3.75 | +0.05 | +1.4% | $3.70 | $3.77 | $3.60 | 300,400 | |
| $3.70 | -0.01 | -0.3% | $3.65 | $3.749 | $3.65 | 202,300 | |
| $3.71 | -0.08 | -2.1% | $3.76 | $3.80 | $3.69 | 201,100 | |
| $3.79 | -0.14 | -3.6% | $3.91 | $3.99 | $3.785 | 202,600 | |
| $3.93 | +0.05 | +1.3% | $3.86 | $3.93 | $3.835 | 282,200 | |
| $3.88 | +0.07 | +1.8% | $3.80 | $3.90 | $3.75 | 274,400 | |
| $3.81 | +0.19 | +5.2% | $3.65 | $3.81 | $3.61 | 359,374 | |
| $3.62 | -0.16 | -4.2% | $3.78 | $3.78 | $3.61 | 602,686 | |
| $3.78 | +0.08 | +2.2% | $3.74 | $3.83 | $3.70 | 195,700 | |
| $3.70 | -0.08 | -2.1% | $3.75 | $3.761 | $3.66 | 229,600 | |
| $3.78 | -0.01 | -0.3% | $3.83 | $3.88 | $3.76 | 701,300 | |
| $3.79 | +0.02 | +0.5% | $3.75 | $3.82 | $3.67 | 351,302 | |
| $3.77 | +0.07 | +1.9% | $3.70 | $3.85 | $3.69 | 232,027 | |
| $3.70 | -0.05 | -1.3% | $3.77 | $3.78 | $3.68 | 324,700 | |
| $3.75 | -0.05 | -1.3% | $3.82 | $3.84 | $3.74 | 256,500 | |
| $3.80 | +0.04 | +1.1% | $3.76 | $3.83 | $3.70 | 307,700 | |
| $3.76 | -0.02 | -0.5% | $3.79 | $3.793 | $3.67 | 311,900 | |
| $3.78 | -0.12 | -3.1% | $3.89 | $3.89 | $3.755 | 297,400 | |
| $3.90 | +0.05 | +1.3% | $3.86 | $3.95 | $3.85 | 343,700 | |
| $3.85 | +0.08 | +2.1% | $3.76 | $3.87 | $3.61 | 280,400 | |
| $3.77 | -0.08 | -2.1% | $3.86 | $3.894 | $3.72 | 284,300 | |
| $3.85 | +0.06 | +1.6% | $3.80 | $3.97 | $3.73 | 1,162,500 | |
| $3.79 | +0.22 | +6.2% | $3.59 | $3.855 | $3.505 | 676,200 | |
| $3.57 | +0.01 | +0.3% | $3.56 | $3.58 | $3.42 | 405,000 | |
| $3.56 | +0.08 | +2.3% | $3.49 | $3.59 | $3.464 | 208,600 |
- Ticker
- NASDAQ:SABS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08: 30 AM ET
Latest earnings call · Aug 6, 2026
SAB Biotherapeutics (NASDAQ:SABS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Apr 22, 2026
Investor Presentation (April 2026)
Investor deck · 30 slides
Calls
Upcoming
SAB Biotherapeutics (NASDAQ:SABS) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:30 AM ET
Register
Replays
SAB Biotherapeutics (NASDAQ:SABS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:30 AM ET
Watch TranscriptSAB Biotherapeutics (NASDAQ:SABS) Q1 2026 Earnings Call
Tue, May 12, 2026 · 8:30 AM ET
Watch Transcript
Latest news
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08: 30 AM ET
Oct 29, 2026
Closed $3.23 (+0.9%) on Oct 29, 2026
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
Oct 14, 2026
Closed $2.49 (-7.1%) on Oct 14, 2026
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
Oct 13, 2026
Closed $2.68 (-5.3%) on Oct 13, 2026
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
Oct 1, 2026
Closed $3.06 (-3.5%) on Oct 1, 2026
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
Sep 22, 2026
Closed $3.50 (+3.2%) on Sep 22, 2026
SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08: 30 AM ET
Jul 30, 2026
Closed $3.56 (+2.3%) on Jul 30, 2026
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Jul 7, 2026
Closed $3.90 (-0.5%) on Jul 7, 2026
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
May 29, 2026
Closed $3.60 (+0.8%) on May 29, 2026
SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights
May 12, 2026
Closed $3.62 (-2.7%) on May 12, 2026
SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08: 30 AM ET
May 5, 2026
Closed $3.68 (-0.3%) on May 5, 2026
Decks
Investor Presentation (April 2026)
Investor deck · 30 slides · Apr 22, 2026
Investor Presentation (March 2026)
Investor deck · 28 slides · Mar 10, 2026
Investor Presentation (January 2026)
Investor deck · 26 slides · Jan 12, 2026
Investor Presentation (2026)
Investor deck · 32 slides · 2026
SAB Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 113 in all · newest Oct 29, 2026 · oldest 2021
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 6, 2026
- Decks
- 19 decks · latest Apr 22, 2026
Where SAB Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SABS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:SABS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about SAB Biotherapeutics, Inc.